Frank Rimerman Advisors’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$78.7K Buy
17,028
+7,025
+70% +$34.8K ﹤0.01% 610
2026
Q1
$46.3K Hold
10,003
﹤0.01% 589
2025
Q4
$50K Hold
10,003
﹤0.01% 600
2025
Q3
$50.7K Sell
10,003
-5,404
-35% -$23.8K ﹤0.01% 593
2025
Q2
$66.4K Hold
15,407
﹤0.01% 561
2025
Q1
$92.9K Sell
15,407
-2,741
-15% -$13.9K 0.01% 510
2024
Q4
$71.7K Buy
18,148
+7,070
+64% +$31.7K 0.01% 515
2024
Q3
$64.8K Buy
11,078
+65
+0.6% +$320 ﹤0.01% 525
2024
Q2
$47.5K Buy
+11,013
New +$52.8K ﹤0.01% 534

Other funds holding MPT

Frank Rimerman Advisors's MPT Position: Q2 2026 in Review

Frank Rimerman Advisors increased its Medical Properties Trust (MPT) stake by 70% in Q2 2026, buying an estimated $34.8K and bringing the position to 17,028 shares worth $78.7K. The position accounts for ﹤0.01% of the portfolio, ranked #610.

Frank Rimerman Advisors first reported a position in MPT in Q2 2024 and has held it in 9 quarters since. The position peaked at $92.9K in Q1 2025. 489 funds tracked by Wall St. Rank hold MPT as of Q2 2026.

  • Frank Rimerman Advisors held 17,028 shares of Medical Properties Trust worth $78.7K as of Q2 2026.
  • Frank Rimerman Advisors bought 7,025 Medical Properties Trust shares in Q2 2026, an estimated $34.8K.
  • Medical Properties Trust made up ﹤0.01% of Frank Rimerman Advisors's portfolio in Q2 2026, its #610 holding.
  • Frank Rimerman Advisors first reported a position in Medical Properties Trust in Q2 2024 and has held it in 9 quarters since.
  • Frank Rimerman Advisors's Medical Properties Trust position peaked at $92.9K in Q1 2025.
  • 489 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2026.

Based on Frank Rimerman Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.